- Report
- January 2022
- 117 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2022
- 239 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- March 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- July 2023
- 80 Pages
United States
From €1426EUR$1,500USD£1,198GBP
- Report
- July 2023
- 80 Pages
United Kingdom
From €1426EUR$1,500USD£1,198GBP
From €1426EUR$1,500USD£1,198GBP
- Report
- July 2023
- 80 Pages
South Korea
From €1426EUR$1,500USD£1,198GBP
- Report
- July 2023
- 80 Pages
Saudi Arabia
From €1426EUR$1,500USD£1,198GBP
- Report
- July 2023
- 80 Pages
India
From €1426EUR$1,500USD£1,198GBP
- Report
- July 2023
- 80 Pages
Germany
From €1426EUR$1,500USD£1,198GBP
- Report
- July 2023
- 80 Pages
France
From €1426EUR$1,500USD£1,198GBP
- Report
- July 2023
- 80 Pages
China
From €1426EUR$1,500USD£1,198GBP
- Report
- July 2023
- 255 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- October 2022
- 101 Pages
Europe
From €1426EUR$1,500USD£1,198GBP
- Report
- August 2024
- 111 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- November 2023
- 73 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- February 2024
- 75 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- July 2023
- 80 Pages
Vietnam
From €1426EUR$1,500USD£1,198GBP
- Report
- July 2023
- 80 Pages
Russia
From €1426EUR$1,500USD£1,198GBP
- Report
- July 2023
- 80 Pages
Poland
From €1426EUR$1,500USD£1,198GBP

The Third Generation Sequencing market within the Biotechnology industry is a rapidly growing sector. It is a technology that enables the sequencing of entire genomes in a single run, allowing for the analysis of complex genomes and the identification of genetic variants. This technology has enabled researchers to gain a better understanding of the genetic basis of diseases, as well as to develop new treatments and diagnostics. It has also enabled the development of personalized medicine, allowing for the development of treatments tailored to an individual's genetic makeup.
The Third Generation Sequencing market is driven by the increasing demand for personalized medicine, as well as the need for more accurate and efficient sequencing technologies. This has led to increased investment in the sector, with many companies developing new technologies and products. Some of the major players in the market include Illumina, Pacific Biosciences, Oxford Nanopore Technologies, 10X Genomics, and BGI. Show Less Read more